Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02184026 · ClinicalTrials.gov registry record · NA
Exposure, Relaxation, & Rescripting Therapy-Child
A NA study, sponsored by University of Montana.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02184026 is a NA study that has completed, run by University of Montana. The registered enrollment target is 2 participants.
The verdict
NCT02184026, a NA study, has completed, sponsored by University of Montana.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The study implements a trauma-related nightmare treatment for children aged 8 to 13 years. Relevant outcome progress and outcome measures on symptoms, nightmare distress and duration, academic indicators, and sleep quality will be examined.
Interventions
- BEHAVIORAL Exposure, Relaxation, & Rescripting Therapy-Child
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2012-12 |
| Est. Completion | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02184026
The ClinicalTrials.gov registry entry for NCT02184026 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Montana, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exposure, Relaxation, & Rescripting Therapy-Child is the first listed.
NCT02184026 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02184026 about?
NCT02184026 is a clinical study titled "Exposure, Relaxation, & Rescripting Therapy-Child". The study implements a trauma-related nightmare treatment for children aged 8 to 13 years. Relevant outcome progress and outcome measures on symptoms, nightmare distress and duration, academic indicators, and sleep quality will be examined.
What is the current status of trial NCT02184026?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2012-12. Estimated completion is 2015-04.
What interventions are being tested in trial NCT02184026?
The interventions under investigation include: Exposure, Relaxation, & Rescripting Therapy-Child (BEHAVIORAL).
Who is sponsoring clinical trial NCT02184026?
This trial is sponsored by University of Montana, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.